Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioXcel Therapeutics (BTAI) Amortization - Deferred Charges (2022 - 2025)

Historic Amortization - Deferred Charges for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to $441000.0.

  • BioXcel Therapeutics' Amortization - Deferred Charges rose 31603.77% to $441000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 15471.01%. This contributed to the annual value of $467000.0 for FY2024, which is 6598.69% down from last year.
  • According to the latest figures from Q3 2025, BioXcel Therapeutics' Amortization - Deferred Charges is $441000.0, which was up 31603.77% from $393000.0 recorded in Q2 2025.
  • Over the past 5 years, BioXcel Therapeutics' Amortization - Deferred Charges peaked at $441000.0 during Q3 2025, and registered a low of $43000.0 during Q1 2024.
  • In the last 4 years, BioXcel Therapeutics' Amortization - Deferred Charges had a median value of $321500.0 in 2022 and averaged $277428.6.
  • As far as peak fluctuations go, BioXcel Therapeutics' Amortization - Deferred Charges plummeted by 8708.71% in 2024, and later skyrocketed by 71395.35% in 2025.
  • Over the past 4 years, BioXcel Therapeutics' Amortization - Deferred Charges (Quarter) stood at $322000.0 in 2022, then fell by 4.66% to $307000.0 in 2023, then decreased by 27.69% to $222000.0 in 2024, then skyrocketed by 98.65% to $441000.0 in 2025.
  • Its Amortization - Deferred Charges stands at $441000.0 for Q3 2025, versus $393000.0 for Q2 2025 and $350000.0 for Q1 2025.